Sort
25,944 grants matching “neurodegeneration”
Development of a Novel Chemokine Receptor Antagonist Peptide as a Synapse Protecting Treatment for Neurodegeneration in Alzheimer's Disease
$449,230Michael R Ruff · Creative Bio-Peptides, Inc. · R43 · FY2020 · AG
Next generation gene expression analysis
$449,210Christine Vogel · New York University · R35 · FY2023 · GM
Ligand Regulated Epigenetic/Nuclear Architectural Strategies and Human Disease
$449,164Michael G Rosenfeld · University Of California, San Diego · R01 · FY2013 · NS
Neuroprotection by IFN-beta in AIDS
$449,089Marcus Kaul · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2011 · MH
Neuroprotection by IFN-beta in AIDS
$449,089Marcus Kaul · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2012 · MH
Basic Neuroscience Training Grant at Columbia University
$449,076David Sulzer · Columbia University Health Sciences · T32 · FY2008 · DA
Molecular Mechanism of LRRK2 Biology and Pathology in Parkinson's Disease
$449,073Zhenyu Yue · Icahn School Of Medicine At Mount Sinai · R01 · FY2017 · NS
Next generation gene expression analysis
$449,065Christine Vogel · New York University · R35 · FY2024 · GM
Structural studies of RNA processing and ubiquitin-like protein modification
$449,000Christopher D Lima · Sloan-Kettering Inst Can Research · R35 · FY2020 · GM
Structural studies of RNA processing and ubiquitin-like protein modification
$449,000Christopher D Lima · Sloan-Kettering Inst Can Research · R35 · FY2019 · GM
Neuronal responses to chronic demyelination
$448,925Ben Emery · Oregon Health & Science University · R01 · FY2023 · NS
Next generation gene expression analysis
$448,916Christine Vogel · New York University · R35 · FY2025 · GM
Nitroxides as Protectors Against Oxidative Stress
$448,821James B Mitchell · Division Of Clinical Sciences - Nci · Z01 · FY2008 · CA
Genetic Control of Programmed Cell Death in Drosphila
$448,780Andreas Bergmann · Univ Of Massachusetts Med Sch Worcester · R01 · FY2014 · GM
Project 4: Novel reagent development to enable molecular characterization
$448,778David Baker · University Of Washington · U19 · FY2022 · AG
Regulation of Mitochondrial Gene Expression and Function by GDF11 Signaling
$448,750Fabio Demontis · St. Jude Children'S Research Hospital · R01 · FY2020 · AG
Role of GSH and MAO-B in PD-related mito dysfunction
$448,625Buck Institute For Age Research · R01 · FY2005 · NS
Project 2: Sleep: Potential Prognostic and Theranostic Marker for Preclinical AD
$448,401David M Holtzman · Washington University · P01 · FY2017 · AG
MITOCHONDRIAL MECHANISMS IN OPTIC NEUROPATHY
$448,373Gino A Cortopassi · University Of California At Davis · R01 · FY2016 · EY
Neurodegeneration with Drosophila
$448,262Baylor College Of Medicine · R01 · FY2003 · NS
Mouse Genetics Core
$448,262Michael S. Levine · University Of California Los Angeles · P50 · FY2008 · NS
The role of lysosomal impairment in trichloroethylene induced Parkinsonian neurodegeneration
$448,243Briana De Miranda · University Of Alabama At Birmingham · R01 · FY2025 · ES
Nonneuronal Mechanisms of Polyglutamine Neurodegeneration
$448,120Hayley Sarah McLoughlin · University Of Michigan At Ann Arbor · R01 · FY2022 · NS
Statistical method for neural mechanism mediating and moderating cognitive system in Alzheimer's disease and aging research.
$448,099Seonjoo Lee · New York State Psychiatric Institute Dba Research Foundation For Mental Hygiene, Inc · R01 · FY2020 · AG
Investigating Mic60 as a Novel Gene Therapy Target for Parkinson's Disease
$448,022Victor Steven Van Laar · Ohio State University · R21 · FY2022 · NS